RESUMO
Transient transfection of rodent fibroblasts with plasmids carrying a full-size pro-alpha1(I) collagen gene (pWTC1) results in rapid reduction of the endogenous transcripts by >90%, while the transgene mRNA is undetectable. Using deletion constructs, two adjacent 5' noncoding regions of the gene are identified as causing transcriptional silencing of the endogene in normal and v-fos-transformed cells but not in nontumorigenic revertants, which show partial relief from v-fos transformation-induced alpha1(I) gene suppression. The 3' end of the transgene carries an additional element(s), causing posttranscriptional silencing of the endogene in all cells including the revertant. Data indicate that the transgenes are transcriptionally self-silenced. Genome-integrated transgenes that are transcriptionally active also allow expression of the endogene, suggesting gene activation by chromosomal factors missing in pWTC1. Silencing is not regulated by antisense RNA. Silencing of the endogenous pro-alpha1(I) collagen gene is not linked to the level of transgene expression.
Assuntos
Colágeno/genética , Processamento Pós-Transcricional do RNA , Transcrição Gênica , Animais , Linhagem Celular , Éxons , Fibroblastos , Íntrons , Camundongos , Pró-Colágeno/genética , RNA Mensageiro , Ratos , TransgenesRESUMO
Genomic DNAs from dimethylbenzanthracene-induced BALB/c mouse mammary tumors arising from the transplantable hyperplastic outgrowth (HPO) line designated DI/UCD transformed NIH 3T3 cells upon transfection. Transforming activity was attributed to the presence of activated Harvey ras-1 oncogenes containing an A----T transversion at the middle adenosine nucleotide in codon 61. DNAs from untreated DI/UCD HPO cells and radiation-induced and spontaneous mammary tumors from the DI/UCD HPO line failed to transform NIH 3T3 cells. The results indicated that the mutation activation of Harvey ras-1 oncogenes was specific to dimethylbenzanthracene treatment in the mouse mammary tumor system.
Assuntos
Transformação Celular Neoplásica , Neoplasias Mamárias Experimentais/genética , Oncogenes , 9,10-Dimetil-1,2-benzantraceno , Animais , Células Cultivadas , Camundongos , Camundongos Endogâmicos , Mutação , Polimorfismo GenéticoRESUMO
In the present study we identified a positive transcriptional element within the rat Ha-ras promoter previously known as Ha-ras response element (HRE) and identified a trans-acting factor that binds HRE sequences in rat mammary cells. To identify the binding protein we employed sequence specific DNA affinity chromatography. Amino acid sequence analysis of the affinity-purified proteins was performed by tandem mass spectroscopy. The results unexpectedly demonstrated that in rat mammary cells CArG box-binding factor A (CBF-A) is the major protein species that bind specifically to the rat and human HRE sequences with high affinity. The affinity of CBF-A binding to HRE was significantly higher than to the CArG box described as a recognition sequence for CBF-A protein. Transient transfection assays using reporter plasmids verified that mutations within the HRE that disrupt binding of CBF-A also reduced the activity of the rat Ha-ras promoter. Despite the fact that the HRE within the Ha-ras promoter resembles a binding site for Ets transcription factors, we did not detect the binding of Ets-related proteins to the rat HRE in BICR-M1Rk cells. We further demonstrated a correlation between the presence of HRE binding activity and induction of Ha-ras mRNA expression following serum stimulation in the mammary carcinoma cell line. Taken together, our results suggest that CBF-A may play an important role in transcriptional regulation of Ha-ras promoter activity during normal mammary cell growth and carcinogenesis.
Assuntos
Proteínas de Ligação a DNA/metabolismo , Regulação Neoplásica da Expressão Gênica , Genes ras/genética , Ribonucleoproteínas Nucleares Heterogêneas Grupo A-B , Regiões Promotoras Genéticas/genética , Proteínas Repressoras/metabolismo , Animais , Antineoplásicos/farmacologia , Sequência de Bases , Western Blotting , Proteínas de Ciclo Celular , Cromatografia de Afinidade , Cromatografia Líquida de Alta Pressão , DNA/genética , DNA/metabolismo , Proteínas de Ligação a DNA/química , Proteínas de Ligação a DNA/isolamento & purificação , Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos , Genes Reporter/genética , Humanos , Espectrometria de Massas , Mimosina/farmacologia , Dados de Sequência Molecular , Peso Molecular , Mutação/genética , Ligação Proteica/efeitos dos fármacos , Proteínas Proto-Oncogênicas/metabolismo , Proteínas Proto-Oncogênicas c-ets , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Ratos , Proteínas Repressoras/química , Proteínas Repressoras/isolamento & purificação , Elementos de Resposta/genética , Ribonucleoproteínas , Termodinâmica , Fatores de Transcrição/metabolismo , Transfecção , Células Tumorais Cultivadas , Raios UltravioletaRESUMO
We previously demonstrated that H-ras1 oncogene mutations detected in N-nitroso-N-methylurea (NMU)-induced mammary tumors arose as background mutations within rat mammary cells (RMCs) and that NMU promoted the outgrowth of these preexisting mutants. We have now detected a putative DNA structure in the H-ras1 promoter of RMCs in vivo that was absent in NMU-induced mammary tumor cells. Analysis of the promoter in RMCs as a function of time after exposure to carcinogens indicated that NMU, but not 7,12-dimethylbenz(a)anthracene, initiated the loss of this structure with a half-life of 7 days. Although loss of the structure was irreversible in cells that gave rise to tumors, it was restored in normal RMCs by 120 days after exposure and was present in normal RMCs of animals bearing tumors, even 1 year after NMU exposure. The structure was also abrogated in RMCs during pregnancy and restored after lactation was terminated, suggesting that reversible regulation of the structure by hormones contributed to normal RMC growth. Thus, NMU may promote abnormal RMC growth by mimicking the effects of hormones on DNA conformation. We hypothesize that the NMU-induced alterations in promoter conformation irreversibly deregulates H-ras1 expression in initiated cells, thereby increasing the phenotypic penetrance of the conditional H-ras1 mutations.
Assuntos
Carcinógenos/toxicidade , DNA de Neoplasias/química , Genes ras , Neoplasias Mamárias Experimentais/genética , Metilnitrosoureia/toxicidade , Conformação de Ácido Nucleico/efeitos dos fármacos , Prenhez/genética , Regiões Promotoras Genéticas/efeitos dos fármacos , Animais , Metilação de DNA , Feminino , Hormônios Esteroides Gonadais/fisiologia , Neoplasias Mamárias Experimentais/induzido quimicamente , Mutação , Reação em Cadeia da Polimerase , Gravidez , Ratos , Ratos Endogâmicos F344RESUMO
We used human tumor cell lines from the National Cancer Institute's In Vitro Antineoplastic Drug Screen to assess whether sensitivity to any of the approximately 45,000 compounds tested previously correlated with the presence of a ras oncogene. Among these cell lines, the mutations in Ki-ras2 clustered in non-small cell lung and colon carcinoma subpanels, and five of the six leukemia lines contained mutations in either N-ras or Ki-ras2. These analyses revealed a striking correlation with 1-beta-D-arabinofuranosylcytosine (Ara-C) and 2,2'-O-cyclocytidine sensitivity in the cell lines harboring ras mutations compared to the tumor lines with wild-type ras alleles. Strong correlations were also found with topoisomerase (topo) II inhibitors, especially 3'-hydroxydaunorubicin and an olivacine derivative. These differential sensitivities persisted in an additional 22 non-small cell lung carcinoma lines (ras mutations, n = 12 and wild-type ras, n = 10). Thus, the association with Ara-C sensitivity was greatest while topo II inhibitors showed a lower, but significant, correlation. These results suggest that the ras oncogene may play a determinant role in rendering tumor cells sensitive to deoxycytidine analogues and topo II inhibitors.
Assuntos
Antimetabólitos Antineoplásicos/farmacologia , Citarabina/farmacologia , Genes ras/genética , Inibidores da Topoisomerase II , Antibióticos Antineoplásicos/administração & dosagem , Antibióticos Antineoplásicos/farmacologia , Antimetabólitos Antineoplásicos/administração & dosagem , Carcinoma Pulmonar de Células não Pequenas/tratamento farmacológico , Carcinoma Pulmonar de Células não Pequenas/genética , Neoplasias do Colo/tratamento farmacológico , Neoplasias do Colo/genética , Citarabina/administração & dosagem , Análise Mutacional de DNA , Daunorrubicina/administração & dosagem , Daunorrubicina/farmacologia , Desoxicitidina/administração & dosagem , Desoxicitidina/análogos & derivados , Desoxicitidina/farmacologia , Resistencia a Medicamentos Antineoplásicos , Ensaios de Seleção de Medicamentos Antitumorais/métodos , Regulação Neoplásica da Expressão Gênica/genética , Humanos , Neoplasias Pulmonares/tratamento farmacológico , Neoplasias Pulmonares/genética , Software , Células Tumorais Cultivadas , GencitabinaRESUMO
We previously described the isolation of non-tumorigenic revertants from mutagenized populations of v-fos-transformed Rat-1 cells (Zarbl et al., 1987). In the present study we examined the possibility that the revertant phenotype resulted from mutations that altered the expression or activities of the c-jun or junB proto-oncogenes. The results demonstrated that levels of the c-jun mRNA and protein were unchanged in the revertants when compared to the transformed parental cells, and ectopic overexpression of c-jun failed to retransform the revertants. Although one mutant allele was detected in revertant EMS-1-19, overexpression of this mutant allele failed to inhibit v-fos induced cell transformation. Together these results indicated that the revertant phenotype did not result from altered expression or mutations in the c-jun gene. In contrast to the results obtained with c-jun, the levels of junB mRNA and protein were found to be reduced two- or threefold in revertant EMS-1-19. Ectopic overexpression of junB induced transformation of revertant EMS-1-19, but failed to transform Rat-1 cells. Moreover, about 10% of v-fos transformed cells transfected with vectors that express antisense junB mRNA acquired a non-transformed phenotype. Together these results indicate that expression of junB above a threshold level is essential for v-fos-induced transformation of Rat-1 fibroblasts.
Assuntos
Transformação Celular Neoplásica , Expressão Gênica , Proteínas Oncogênicas v-fos/genética , Proteínas Proto-Oncogênicas c-jun/genética , Alelos , Animais , Linhagem Celular Transformada , Transformação Celular Neoplásica/efeitos dos fármacos , Células Cultivadas , Genes jun , Proteínas Oncogênicas v-fos/fisiologia , RNA Antissenso/farmacologia , RatosRESUMO
Some single-nucleotide polymorphisms (SNPs) increase the risk of mortal disease. Identifying these SNPs and the genes in which they reside is an important area in human genomics. Such qualitative observations are important in themselves. However, an accurate assessment of the numerical distribution and age-dependent decline of SNPs in the population would permit calculation of the rises represented by each SNP. Such analyses have not been attempted because of a lack of an efficient and cost-effective method to detect multiple SNPs in a large number of individuals and a large number of genes. Here, we suggest the use of an analytical procedure that can scan for SNPs in 100-bp DNA sequences from as many as 10000 donors' blood cell samples, or 20000 alleles, simultaneously. Our suggestion is based on technology developed for studies of somatic mutations in human tissue DNA for point mutations at frequencies equal to or greater than 10(-6). In a simplified version of this technology, any SNP arising at frequencies at or above 5x10(-4) would be identified with useful precision. A gene would be represented by 10 or more sections of 100bp. This strategy includes splice-site mutations that represent a significant fraction of gene inactivating point mutations and would not be observed in strategies using cDNA. To illustrate the logic of the suggested approach, we use American mortality records to calculate the expected decrease in SNPs coding for premature mortality in newborns and centenarians. We consider several elementary cases: SNPs in one gene only, any of several genes, or all of several genes that create a risk of death by pancreatic cancer. The fraction of expressed polymorphisms affecting mortality should be simultaneously increased in probands and decreased in the aged relative to newborns. Silent polymorphisms in the same gene would remain unchanged in all three groups and serve as internal standards. A key point is that scanning a gene, in which loss of gene function creates the risk of mortality is expected to reveal not one, but multiple SNPs, which decline with age, as carriers die earlier in life than non-carriers. Several SNPs in a scanned gene would suggest that the decreasing SNP was genetically linked to a different polymorphism that creates the disease risk.
Assuntos
Doenças Genéticas Inatas/genética , Genética Populacional , Modelos Genéticos , Polimorfismo Genético , Fatores Etários , Idoso , Idoso de 80 Anos ou mais , Coleta de Amostras Sanguíneas , Eletroforese Capilar , Feminino , Doenças Genéticas Inatas/epidemiologia , Predisposição Genética para Doença/genética , Humanos , Recém-Nascido , Masculino , Modelos Biológicos , Mutação , Neoplasias Pancreáticas/genética , Reação em Cadeia da Polimerase , Fatores de Risco , Estados UnidosRESUMO
Malignant transformation may be viewed as an imbalance between signals inducing cell growth and signals leading to growth inhibition, differentiation, or senescence. A basic understanding of how these counterbalancing forces interact to regulate normal cell growth is the prerequisite to comprehending the mechanisms of tumorigenesis. Identification and characterization of the gene products implicated in these regulatory pathways is the first step toward understanding the disease process. The studies outlined here provide the potential basis for isolating and molecularly characterizing transformation effector and suppressor genes, which must respectively function in the positive and negative regulation of normal cell growth. The general strategy used involves the isolation and molecular characterization of nontransformed variants (revertants) from populations of tumor cells. The selection of revertants is facilitated by the ability to separate normal from transformed cells by fluorescence-activated sorting. The basis for this separation is the differential retention of the fluorescent dye rhodamine 123 in the mitochondria of normal versus transformed cells. Using this approach, we have isolated revertants from a mutagenized population of v-fos-transformed Rat-1 fibroblasts. Characterization of these clones indicated that they had sustained causal mutations in transformation effector genes. The unmutated effector genes are being identified and molecularly cloned by isolating retransformed clones from revertant cell lines that have been transfected with DNA or cDNA from normal primary cells. The same selection protocol has also been used to isolate revertants from tumor cell lines that have been transfected with DNA or cDNA from primary cells. The putative tumor-suppressor genes present in these revertants are currently being analyzed.
Assuntos
Transformação Celular Neoplásica/genética , Genes Supressores de Tumor , Técnicas Genéticas , Oncogenes , Animais , Fusão Celular , Linhagem Celular Transformada , Separação Celular , Transformação Celular Neoplásica/metabolismo , Mapeamento Cromossômico , Clonagem Molecular/métodos , Fibroblastos , Citometria de Fluxo , Corantes Fluorescentes/farmacocinética , Genes Dominantes , Genes do Retinoblastoma , Camundongos , Camundongos Nus , Mitocôndrias/metabolismo , Neoplasias Experimentais/genética , Proteínas Oncogênicas v-fos/genética , Proteínas Oncogênicas v-fos/metabolismo , Polimorfismo de Fragmento de Restrição , Proto-Oncogenes , Ratos , Rodamina 123 , Rodaminas/farmacocinética , Roedores , Seleção Genética , TransfecçãoRESUMO
We introduce a method to efficiently detect rare mutations for individual subjects in a large population by pooling samples and retesting subgroups of positive pooled samples. We conducted computer simulations of this method and discovered that it seems efficient for mutation prevalences less than 0.1, regardless of the number of samples. The simulations also indicate that splitting the pooled samples into three to five subgroups at each level is optimal. The expected number of necessary tests and relative efficiency of this method are given, by mutation prevalence and sample size.
Assuntos
Testes Genéticos/métodos , Mutação , Simulação por Computador , Análise Mutacional de DNA , Frequência do Gene , Genótipo , Humanos , PrevalênciaAssuntos
Células L , Orthoreovirus Mamífero 3/genética , Biossíntese de Proteínas , Reoviridae/genética , Eletroforese em Gel de Poliacrilamida , Orthoreovirus Mamífero 3/metabolismo , Modelos Genéticos , Biossíntese Peptídica , RNA Mensageiro/isolamento & purificação , RNA Viral/isolamento & purificação , Transfecção , Proteínas Virais/biossínteseAssuntos
Genes ras , Mutação Puntual , Primers do DNA/genética , DNA de Neoplasias/química , DNA de Neoplasias/genética , DNA de Neoplasias/isolamento & purificação , Eletroforese em Gel de Poliacrilamida/métodos , Humanos , Desnaturação de Ácido Nucleico , Ácidos Nucleicos Heteroduplexes/química , Reação em Cadeia da Polimerase , Células Tumorais CultivadasRESUMO
DNA microarrays or chips can be used to simultaneously monitor the expression levels and/or genotypes of thousands of genes. The application of these techniques heralds a new era in toxicology research, where genotypes and toxicant-induced expression signatures may be used to monitor cellular responses to different doses, to classify toxins on the basis of their mechanisms of action, to monitor exposures, and to predict individual variability in toxicant sensitivity. This unit reviews the current state of microarray technologies and discusses potential applications in toxicology, with emphasis on the strengths and limitations of the technologies.
Assuntos
Perfilação da Expressão Gênica/métodos , Análise de Sequência com Séries de Oligonucleotídeos , Testes de Toxicidade/métodos , Toxicologia/métodos , Animais , Biologia Computacional , Regulação da Expressão Gênica/efeitos dos fármacos , Humanos , Polimorfismo de Nucleotídeo Único , Medição de RiscoRESUMO
Reovirus progeny subviral particles were isolated from L-cells at late times postinfection. It has been shown (D. Skup and S. Millward, J. Virol. 34: 490--496, 1980) that these progeny subviral particles have masked capping enzymes, indicating that mRNA synthesized by these particles should be uncapped. When progeny subviral particles were used for mRNA synthesis in vitro, they failed to incorporate the beta-phosphate of [beta-32P]GTP into the 5' terminal. Direct analysis of reovirus mRNA synthesized by progeny subviral particles in the presence of either [alpha-32P]GTP or [alpha-32P]CTP indicated that the 5' terminal was uncapped, having the structure pGpC... The implications of this finding to the reovirus replicative cycle are discussed.
Assuntos
Orthoreovirus Mamífero 3/metabolismo , Capuzes de RNA/metabolismo , RNA Mensageiro/biossíntese , RNA Viral/biossíntese , Reoviridae/metabolismo , Quimotripsina/farmacologia , Orthoreovirus Mamífero 3/crescimento & desenvolvimento , Biossíntese de Proteínas , RNA Mensageiro/análise , RNA Mensageiro/genética , RNA Viral/análise , RNA Viral/genética , Vírion/metabolismoRESUMO
Much has been learned about the molecular basis of cancer from the study of the dominantly acting viral and cellular oncogenes and their normal progenitors, the proto-oncogenes. More recent studies have resulted in the isolation and characterization of several genes prototypic of a second class of cancer genes. Whereas oncogenes act to promote the growth of cells, members of this latter class of genes act to inhibit cellular growth and are believed to contribute to the tumorigenic phenotype only when their activities are absent. This new class of cancer genes is referred to by a number of different names including; anti-oncogenes, recessive oncogenes, growth suppressor genes, tumor suppressor genes and emerogenes. Although only a few of these cancer genes have been identified, to date, it is likely that many additional genes of this class await identification. A third class of genes, necessary for the development of the cancer phenotype, is comprised of the transformation effector genes. These are normal cellular genes that encode proteins that cooperate with or activate oncogene functions and thereby induce the development of the neoplastic phenotype. The inactivation of transformation effector functions would therefore inhibit the ability of certain dominantly acting oncogenes to transform cells. The approaches outlined here describe functional assays for the isolation and molecular characterization of transformation effector and suppressor genes.
Assuntos
Transformação Celular Neoplásica/genética , Genes Supressores de Tumor , Oncogenes , Animais , Regulação Neoplásica da Expressão Gênica , Humanos , Neoplasias/etiologia , Neoplasias/genética , FenótipoRESUMO
Two proteins expressed in Rat-1 cells which are targets for v-fos transformation-specific alterations in gene expression were identified as alpha 1(I) and alpha 2(I) procollagen. While procollagen (I) proteins were synthesized in Rat-1 fibroblasts, their synthesis was dramatically reduced in Rat-1 cells transformed with the FBJ-v-fos oncogene. Revertant cell lines, which were previously shown to express a functional fos oncoprotein, resumed the synthesis of procollagen (I) at levels comparable to those seen in Rat-1 cells. Further results indicated that these procollagen proteins were also synthesized in Rat-1 cell lines that constitutively express high levels of a transfected c-fos protooncogene. Together, these observations suggested that constitutive fos protein expression was not sufficient to inhibit synthesis of these proteins. We have further demonstrated that Rat-1 cells transformed by most other oncogenes express abundant levels of procollagen (I), indicating that inhibition of procollagen (I) synthesis is not a general characteristic of transformed Rat-1 cells but is specifically associated with FBJ-v-fos-induced transformation. Northern blot analysis and runoff transcription assay data indicated that the alpha 1(I) procollagen, but not alpha 2(I) procollagen, is differentially regulated at the transcriptional level in Rat-1 fibroblasts, v-fos transformants, and revertants.
Assuntos
Transformação Celular Neoplásica/genética , Proteínas Oncogênicas Virais/genética , Pró-Colágeno/biossíntese , Sequência de Aminoácidos , Animais , Linhagem Celular , Linhagem Celular Transformada , Regulação Neoplásica da Expressão Gênica , Glicosilação , Dados de Sequência Molecular , Peso Molecular , Proteínas Oncogênicas v-fos , Pró-Colágeno/genética , Processamento Pós-Transcricional do RNA , RNA Mensageiro/biossíntese , Ratos , Transcrição GênicaRESUMO
Valid comparisons of gene promoter activities between different cell lines, and within a cell line, critically depend on accurate measurements of the number of genes introduced into the nuclei of cells. We have developed a simple method that allows direct and accurate quantitation of transfected plasmid DNA in cultured cells. The transfected DNA present in nuclei is copurified with genomic DNA without using phenol/chloroform extractions. DNA is amplified by PCR, and the amount of transfected DNA is read directly from a standard curve. By using the procedures described in this report, we have studied the relative expression of the Escherichia coli beta-galactosidase gene, driven by the wild-type Mo-MuLV LTR, in Rat-1 fibroblasts, FBJ v-fos-transformed Rat-1 (1302), and a revertant of v-fos-transformant (EMS-1-19) cell lines. The relative levels of expression of the transgene at 22 hr post-transfection in these three cell lines were 1:4:1, respectively, and at 48 hr post-transfection the respective ratios were 1:10.6:4. These results have significant implications for the use of cotransfected internal control plasmids to normalize data from transient transfection experiments to study promoter activities among different cell lines.
Assuntos
Transformação Celular Neoplásica , Genes fos , Reação em Cadeia da Polimerase/métodos , Regiões Promotoras Genéticas , beta-Galactosidase/biossíntese , Animais , Linhagem Celular , Núcleo Celular/metabolismo , DNA/análise , DNA/isolamento & purificação , DNA/metabolismo , Eletroporação , Endopeptidase K , Expressão Gênica , Cinética , Vírus da Leucemia Murina de Moloney , Plasmídeos , Ratos , Proteínas Recombinantes/análise , Proteínas Recombinantes/biossíntese , Sequências Repetitivas de Ácido Nucleico , Serina Endopeptidases , Transfecção , beta-Galactosidase/análiseRESUMO
Morphologic revertants of FBJ murine sarcoma virus (v-fos)-transformed rat-1 fibroblasts were isolated using a novel selection procedure based on prolonged retention of rhodamine 123 within mitochondria of v-fos-transformed versus normal fibroblasts. Two classes of revertants were isolated: class I revertants have sustained mutations in cellular genes, and a class II revertant has a nonfunctional v-fos provirus. Somatic-cell hybridization studies suggested that the revertant phenotype was recessive to the transformed phenotype. Class I revertants were also resistant to retransformation by v-gag-fos-fox, v-Ha-ras, v-abl, and v-mos, but could be retransformed by the trk oncogene and polyoma virus middle T antigen. These results suggest that the class I revertants sustained mutations in one or more cellular genes essential for transformation by some, but not all, oncogenes. Our data suggest the existence of common biochemical pathways for transformation.
Assuntos
Transformação Celular Neoplásica , Genes , Mutação , Oncogenes , Sarcoma Experimental/patologia , Animais , Linhagem Celular , Células Clonais , Fibroblastos/citologia , Camundongos , Proteínas de Neoplasias/genética , Proteínas de Neoplasias/isolamento & purificação , Ratos , Sarcoma Experimental/genéticaRESUMO
Revertants were isolated from v-fos-transformed rat-1 cells cotransfected with a human cDNA expression library and a selectable marker (pMEX-neo). Molecular analysis of one clone, R2.2, suggested that the revertant phenotype resulted from the disruption of a transformation effector gene by the integration of the pMEX-neo plasmid. Genomic sequences flanking the plasmid integration site were cloned and used as probes in Northern blot analyses. A probe derived from sequences 5' to the integration site hybridized to a unique 1.2-kilobase mRNA and was used to isolate a 0.9-kilobase cDNA clone (fte-1). The open reading frame of the fte-1 cDNA predicts a highly basic protein that shows a remarkable level of similarity with two genes from Saccharomyces cerevisiae. One of these yeast genes contains an unidentified open reading frame and the other, MFT1, is a gene isolated from a yeast mutant that fails to import a fusion protein into mitochondria [Garrett, J. M., Singh, K. K., Vonder Haar, R. A. & Emr, S. D. (1991) Mol. Gen. Genet. 225, 483-491]. Expression of the fte-1 gene was induced approximately 5-fold in v-fos-transformed fibroblasts, but expression was reduced in clone R2.2 and in several independent revertant clones. Transfection of R2.2 cells with fte-1 expression vectors resulted in the reacquisition of a transformed phenotype. These results demonstrate that the mammalian homologue of a gene implicated in protein import into yeast mitochondria is a v-fos transformation effector gene.
Assuntos
Proteínas de Transporte/genética , Transformação Celular Viral/genética , Genes Fúngicos , Genes fos , Mitocôndrias/metabolismo , Proteínas Ribossômicas , Saccharomyces cerevisiae/genética , Sequência de Aminoácidos , Animais , Sequência de Bases , Southern Blotting , Linhagem Celular , Linhagem Celular Transformada , Células Cultivadas , Células Clonais , DNA/genética , DNA/isolamento & purificação , Biblioteca Gênica , Humanos , Dados de Sequência Molecular , Fases de Leitura Aberta , Plasmídeos , RNA Mensageiro/genética , Ratos , Mapeamento por Restrição , Saccharomyces cerevisiae/metabolismo , Homologia de Sequência do Ácido Nucleico , TransfecçãoRESUMO
Uncapped reovirus mRNA extracted at late times from infected L-cells is preferentially translated in extracts from infected L-cells. However, translation of this uncapped, late, reovirus mRNA in extracts from infected cells is sensitive to inhibition by the cap analog m7GTP . These results imply that reovirus infection does not induce a transition from cap-dependent to cap-independent translation. Nevertheless, the results of in vitro translational competition experiments between L-cell mRNA and late viral mRNA were consistent with the view that reovirus does induce an alteration in the cap-dependent translational apparatus of L-cells. The reduced efficiency of translation of a variety of capped mRNAs in extracts from infected cells is also consistent with this notion. We further conclude that a factor exists in reovirus-infected L-cells that specifically stimulates translation of uncapped reovirus mRNAs.